News | Proton Therapy | December 07, 2015

U.S. Veterans With Chronic Pain Could Find Relief From Proton Therapy

military vet

November 7, 2015 —As the nation prepares to honor its military this Veteran’s Day, physician-scientists at Loma Linda University Cancer Center’s (LLUCC’s) James M. Slater, M.D., Proton Treatment & Research Center are studying how proton therapy can be used to help relieve chronic pain afflicting hundreds of thousands of U.S. military service members and veterans.

According to a report from the Institute of Medicine, nearly 100 million American adults suffer from chronic pain with that ailment disproportionately affecting those who have served or are serving in the military. In fact, according to a June 2014 report in JAMA Internal Medicine, 44 percent of U.S. military veterans suffered with chronic pain compared to 26 percent of the general public. In addition to the tragic pain, suffering and emotional toll to these veterans and their families, this costs the American healthcare system $635 billion per year.

“Our study is focusing on the nerve areas where the pain is coming from. We are targeting those areas with proton beam radiation to neutralize the pain so the brain doesn’t interpret it as a painful area,” said Jerry D. Slater, M.D., chairman and medical director of the LLUCC Department of Radiation Medicine and James M. Slater, MD, Proton Treatment & Research Center. “We hope that by neutralizing the pain, we can help decrease the need for pain medication, which not only is expensive, but can also have disabling side effects.”

Many U.S. service members and veterans with pain also have related conditions such as post-traumatic stress syndrome or traumatic brain injury; and as the JAMA report also noted, many of these individuals are at risk for a lifetime progression of increasing disability. Without less-costly and effective pain management solutions, it’s estimated that costs related to care and disability will approach $5 trillion.

Proton beams are specifically programmed to reach the exact depth needed to release their maximum energy, which targets only the designated treatment area while sparing surrounding healthy tissue. As a result, the treatment benefits are significantly maximized while unwanted side effects are greatly reduced.

Loma Linda is the only proton center in the world researching proton’s effect on relieving chronic pain. “We salute our nation’s veterans and thank them for their years of service for our country,” Slater said. “Through this study we hope to ameliorate the chronic pain that affects so many veterans so they can truly enjoy the life they fought so hard to preserve.”

For more information: www.lomalindahealth.org

Related Content

Turkish Hospital Begins MR-Guided Radiation Therapy With Viewray MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | September 21, 2018
ViewRay Inc. announced that Acibadem Maslak Hospital in Istanbul, Turkey has begun treating patients with ViewRay's...
Machine Learning IDs Markers to Help Predict Alzheimer's

Neurologists use structural and diffusion magnetic resonance imaging (MRI) to identify changes in brain tissue (both gray and white matter) that are characteristic of Alzheimer's disease and other forms of dementia. The MRI images are analyzed using morphometry and tractography techniques, which detect changes in the shape and dimensions of the brain and in the tissue microstructure, respectively. In this example, the images show the normal brain of an elderly patient. Image courtesy of Jiook Cha.

News | Neuro Imaging | September 20, 2018
New research has shown a combination of two different modes of magnetic resonance imaging (MRI), computer-based...
Amar Kishan, M.D.

Amar Kishan, M.D.

News | Prostate Cancer | September 11, 2018
UCLA researchers have discovered that a combination of high doses of...
Videos | Radiation Therapy | September 07, 2018
A discussion with Ehsan Samei, Ph.D., DABR, FAAPM, FSPIE, director of the Duke University Clinical Imaging Physics Gr
Boston Scientific to Acquire Augmenix Inc.
News | Patient Positioning Radiation Therapy | September 07, 2018
Boston Scientific has entered into a definitive agreement to acquire Augmenix Inc., a privately-held company which has...
PET Imaging Agent Predicts Brain Tau Pathology, Alzheimer's Diagnosis
News | PET Imaging | September 05, 2018
Eli Lilly and Co. and Avid Radiopharmaceuticals Inc. announced a Phase 3 study of positron emission tomography (PET)...
Check-Cap Announces Interim Results of European Study of C-Scan System Version 3
News | Colonoscopy Systems | September 04, 2018
Check-Cap Ltd. announced the interim results for its post-CE approval study of the C-Scan system Version 3, an...
Brain Iron Levels May Predict Multiple Sclerosis Disabilities
News | Neuro Imaging | August 31, 2018
A new, highly accurate magnetic resonance imaging (MRI) technique can monitor iron levels in the brains of multiple...
Study Finds Multiple Sclerosis Drug Slows Brain Shrinkage

An NIH-funded clinical trial suggested that the anti-inflammatory drug ibudilast may slow brain shrinkage caused by progressive MS. Image courtesy of Robert J. Fox, M.D., Cleveland Clinic.

News | Neuro Imaging | August 30, 2018
August 30, 2018 — Results from a clinical...
Non-Canonical Strategy May Improve Cancer Radiotherapy
News | Radiation Therapy | August 29, 2018
August 29, 2018 — Although the success or failure of...